AZ vs MSFT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The company exhibits extremely weak financial health with a Piotroski F-Score of just 1/9, indicating severe operational and profitability concerns. Despite strong short-term earnings surprises and a bullish analyst target price of $30.00, the firm remains deeply unprofitable with negative operating margins (-265.87%), negative ROE (-89.37%), and declining year-over-year revenue (-1.60%). High valuation multiples, including a Price/Sales ratio of 41.74, suggest the stock is pricing in aggressive future growth not supported by current fundamentals. While liquidity ratios are strong and debt is minimal, the lack of profitability and inconsistent earnings trajectory raise material sustainability concerns.
Microsoft exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust financial stability. While the stock is currently experiencing a severe technical downtrend (0/100) and significant 6-month price depreciation (-28.6%), the current price of $374.33 sits well below the growth-based intrinsic value of $471.41 and the analyst target of $587.31. Exceptional earnings growth (59.8% YoY) and high operating margins (47.09%) suggest that the current price correction presents a value opportunity despite bearish insider sentiment.
Compare Another Pair
Related Comparisons
AZ vs MSFT: Head-to-Head Comparison
This page compares A2Z Cust2Mate Solutions Corp. (AZ) and Microsoft Corporation (MSFT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.